Sibutramine is effective for weight loss and diabetic control in obesity with type 2 diabetes: A randomised, double-blind, placebo-controlled study

Diabetes, Obesity and Metabolism

Volumn 2, Issue 2, 2000, Pages 105-112

  Finer, N ^a   Bloom, S R ^b   Frost, G S ^b   Banks, L M ^b   Griffiths, J ^b  

^a LUTON AND DUNSTABLE HOSPITAL   (United Kingdom)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; GLYCOSYLATED HEMOGLOBIN; INSULIN; METFORMIN; PLACEBO; SIBUTRAMINE; SULFONYLUREA;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; BODY COMPOSITION; BODY MASS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET RESTRICTION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DUAL ENERGY X RAY ABSORPTIOMETRY; ELECTROCARDIOGRAM; FEMALE; GASTROINTESTINAL SYMPTOM; GLUCOSE BLOOD LEVEL; HEADACHE; HIP; HUMAN; INFECTION; INSOMNIA; LABORATORY TEST; LOW CALORY DIET; MALE; MEAL; MEASUREMENT; MONITORING; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OUTPATIENT DEPARTMENT; PHARYNGITIS; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS; VERTIGO; WEIGHT REDUCTION;

EID: 0034520443     PISSN: 14628902     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1463-1326.2000.00071.x     Document Type: Article

References (28)

1. Evolution from obesity to diabetes
2. Medical hazards of obesity
3. Current estimates of the economic cost of obesity in the United States
4. Weight as a risk factor for clinical diabetes in women
5. Health implications of overweight and obesity in the United States
6. Obesity, weight loss and prognosis in type 2 diabetes
7. Long-term effects of modest weight loss in type II diabetic patients
8. Beneficial effect of moderate weight loss in older patients with non-insulin-dependent diabetes mellitus poorly controlled with insulin
9. Influence of treatment with diet alone on oral glucose-tolerance test and plasma sugar and insulin levels in patients with maturity-onset diabetes mellitus
10. Variables associated with weight loss and improvements in glycemic control in type II diabetic patients in behavioral weight control programs
11. Sex differences in weight loss among adults with type II diabetes mellitus
12. Limitations of diet therapy in patients with non-insulin-dependent diabetes mellitus
13. Moderate weight loss and sulfonylurea treatment of non-insulin-dependent diabetes mellitus: Combined effects
14. Insulin secretion improves following dietary control of plasma glucose in severely hyperglycemic obese patients
15. Sibutramine: A review of the pharmacology of a novel anti-obesity agent
16. Sibutramine: A review of clinical efficacy
17. Long-term maintenance of weight loss after a very-low-calorie diet: A randomized blinded trial of the efficacy and tolerability of sibutramine
18. Prescription of diabetic diets in the 1980s
19. Dietary recommendations for people with diabetes: An update for the 1990s
20. A new method of energy prescription to improve weight loss
21. Dual-energy X-ray absorbiometry body composition model: Review of physical concepts
22. How to improve the medical quality of the coding reports based on WHO-ART and COSTART use
23. A double-blind randomized placebo-controlled trial of sibutramine
24. Sibutramine produces dose-related weight loss
25. Understanding oral glucose tolerance: Comparison of glucose or insulin measurements during the oral glucose tolerance test with specific measurements of insulin resistance and insulin secretion
26. Sibutramine in the treatment of obese type II diabetics
27. Sibutramine induces weight loss and improves glycemic control in obese patients with type 2 diabetes mellitus